Park Ju Ae, Pham Duy, Nilsson Kasper, Ramsey Lolita, Morris Diana, Khandhar Sandeep J, Weyant Michael J, Suzuki Kei
Department of Surgery, Inova, Fairfax, VA.
University of Virginia School of Medicine, Charlottesville, VA.
Clin Lung Cancer. 2025 Mar;26(2):140-145. doi: 10.1016/j.cllc.2024.11.010. Epub 2024 Nov 16.
Thoracic Enhanced Recovery with Ambulation after Surgery (T-ERAS) protocol at our institution includes ambulation into the operating room and 250-feet ambulation within 1 hour of extubation. We compared the average length of stay (LOS) between T-ERAS patients and that predicted using a validated surgical risk calculator.
We retrospectively reviewed patients undergoing lung cancer resection with minimally invasive approach from 2012 to 2022. Patients aged ≥ 18 were included if early ambulation was documented. Patient information were entered into the American College of Surgeon's National Surgical Quality Improvement Program Risk Calculator (NSQIP) to obtain the predicted LOS. Descriptive statistics, comparisons of observed versus predicted LOS (O/P ratio), and nonparametric testing were conducted.
Of 940 patients reviewed, 886 met eligibility. For the study cohort, average age was 68, and 514 (58.0%) were female. By procedure, there were 631(71.2%) lobectomy, 204 (23.0%) wedge, 26 (2.9%) segmentectomy, 20 (2.3%) bilobectomy, and 5 (0.6%) pneumonectomy. The average LOS observed for the entire cohort was 1.2 days (median 1.0 day) compared to the predicted LOS of 3.4 days with the NSQIP (median 4.0). Overall, 842 (95%) of patients had LOS better than predicted (O/P ratio < 1), 19 (2.1%) had LOS as predicted (O/P ratio = 1), and 25 (2.8%) had LOS longer than predicted (O/P ratio > 1). The mean O/P ratio was 0.34.
Average LOS with T-ERAS protocol was 1.2 days compared to the predicted average of 3.6 days in patients undergoing minimally invasive lung cancer resections. Our study provides a potential protocol to shorten the LOS beyond what is predicted by NSQIP.
我们机构的术后早期活动的胸段加速康复(T-ERAS)方案包括在手术室内行走以及拔管后1小时内行走250英尺。我们比较了T-ERAS患者的平均住院时间(LOS)与使用经过验证的手术风险计算器预测的住院时间。
我们回顾性分析了2012年至2022年接受微创肺癌切除术的患者。如果有早期活动记录,则纳入年龄≥18岁的患者。将患者信息输入美国外科医师学会国家外科质量改进计划风险计算器(NSQIP)以获得预测的住院时间。进行描述性统计、观察到的与预测的住院时间比较(O/P比值)以及非参数检验。
在940例接受评估的患者中,886例符合条件。研究队列的平均年龄为68岁,514例(58.0%)为女性。按手术方式,有631例(71.2%)肺叶切除术、204例(23.0%)楔形切除术、26例(2.9%)肺段切除术、20例(2.3%)双肺叶切除术和5例(0.6%)全肺切除术。整个队列观察到的平均住院时间为1.2天(中位数1.0天),而NSQIP预测的住院时间为3.4天(中位数4.0天)。总体而言,842例(95%)患者的住院时间优于预测值(O/P比值<1),19例(2.1%)患者的住院时间与预测值相同(O/P比值=1),25例(2.8%)患者的住院时间长于预测值(O/P比值>1)。平均O/P比值为0.34。
接受微创肺癌切除术的患者采用T-ERAS方案的平均住院时间为1.2天,而预测的平均住院时间为3.6天。我们的研究提供了一种潜在方案,可将住院时间缩短至NSQIP预测值以下。